Most patients reported positively or neutrally of having served as controls in the trials within cohorts design

To evaluate patients’ experience of having served as controls without a notification at the time of randomization in the context of the trial within cohorts (TwiCs) design. Patients were asked for their opinion on having served as controls in TwiCs, before and after having been provided the trial re...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical epidemiology 2022-08, Vol.148, p.39-47
Main Authors: Verweij, Maaike E., Gal, Roxanne, Burbach, J.P. Maarten, Young-Afat, Danny A., van der Velden, Joanne M., van der Graaf, Rieke, May, Anne M., Relton, Clare, Intven, Martijn P.W., Verkooijen, Helena M.
Format: Article
Language:English
Subjects:
Breast cancer
Broad consent
Cancer therapies
Clinical trials
Colorectal cancer
Consents
Design
Epidemiology
Ethics
Explicit knowledge
Informed consent
Intervention
Medical ethics
Participation
Patients
Patients' experience
Questionnaires
Radiation dosage
Radiation therapy
Randomization
Randomized controlled trials
Statistical analysis
Trials within cohorts
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate patients’ experience of having served as controls without a notification at the time of randomization in the context of the trial within cohorts (TwiCs) design. Patients were asked for their opinion on having served as controls in TwiCs, before and after having been provided the trial results. Patients had provided broad consent to randomization at cohort entry and had served as controls in one of two TwiCs (an exercise program after breast cancer treatment or radiotherapy dose-escalation for rectal cancer). Two to 6 years after cohort entry, 15% (n = 16) of all patients remembered having provided broad consent to randomization. Before disclosure of trial results, 47% (n = 52) of patients thought positively, 45% (n = 50) neutrally, and 2% (n = 2) negatively of having served as controls in one of the two trials. Seventeen percent (n = 18) of patients were positive, 65% (n = 71) neutral, and 11% (n = 12) negative about not having been notified when serving as controls. The survey results were comparable after disclosure of trial results. These results support the use of the TwiCs design with the staged-informed consent procedure. Keeping patients engaged and aware of the consents provided might further improve patients’ experience of serving as controls in TwiCs.
ISSN:0895-4356
1878-5921
DOI:10.1016/j.jclinepi.2022.04.015